...
首页> 外文期刊>Molecular medicine reports >Screening of the prognostic targets for breast cancer based co-expression modules analysis
【24h】

Screening of the prognostic targets for breast cancer based co-expression modules analysis

机译:基于乳腺癌的共表达模块分析的预后靶向筛选

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of the present study was to screen the prognostic targets for breast cancer based on a co-expression modules analysis. The microarray dataset GSE73383 was downloaded from the Gene Expression Omnibus (GEO) database, including 15 breast cancer samples with good prognosis and 9 breast cancer samples with poor prognosis. The differentially expressed genes (DEGs) were identified with the limma package. The Database for Annotation, Visualization and Integrated Discovery was used to perform Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. Furthermore, the co-expression analysis of DEGs was conducted with weighted correlation analysis. The interaction associations were analyzed with the Human Protein Reference Database and BioGRID. The protein-protein interactions (PPI) network was constructed and visualized by Cytoscape software. A total of 491 DEGs were identified in breast cancer samples with poor prognosis compared with those with good prognosis, and they were enriched in 85 GO terms and 4 KEGG pathways. 368 DEGs were co-expressed with others, and they were clustered into 10 modules. Module 6 was the most relevant to the clinical features, and 21 genes and 273 interaction pairs were selected out. Abnormal expression levels of required for meiotic nuclear division 5 homolog A (RMND5A) and angiopoietin-like protein 1 (ANGPTL1) were associated with a poor prognosis. It was indicated that SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily D, member 1, SWI/ SNF related, matrix associated, actin dependent regulator of chromatin, subfamily D, member 1, dihydropyrimidinase-like 2, RMND5A and ANGPTL1 were potential prognostic markers in breast cancer, and the cell cycle may be involved in the regulation of breast cancer.
机译:本研究的目的是基于共表达模块分析筛选乳腺癌的预后靶标。微阵列数据集GSE73383从基因表达综合症(Geo)数据库下载,包括15名乳腺癌样本,具有良好的预后和9个乳腺癌样品,预后差。用氨纶包鉴定差异表达的基因(DEGS)。用于注释,可视化和集成发现的数据库用于进行基因本体(GO)和京都基因和基因组(KEGG)途径富集分析。此外,用加权相关分析进行DEG的共表达分析。用人蛋白参考数据库和生物格进程分析相互作用缔合。通过Cytoscape软件构建和可视化蛋白质 - 蛋白质相互作用(PPI)网络。与具有良好预后的人相比,总共491只患有预后差的乳腺癌样品,它们富含85条术语和4 Kegg途径。 368次与他人共同表达,它们被聚集成10个模块。模块6是与临床特征最相关的,选择21个基因和273个相互作用对。减数分裂核划分5同源物(RMND5A)和血管翅素样蛋白1(Angptl1)所需的异常表达水平与预后差有关。结果表明,SWI / SNF相关,基质相关,肌动蛋白依赖性调节剂的染色质,亚家族D,构件1,SWI / SNF相关,基质相关,染色蛋白依赖性调节剂的染色质,亚家族D,构件1,二氢嘧啶酶样2,RMND5A Angptl1在乳腺癌中是潜在的预后标志物,细胞周期可能参与乳腺癌的调节。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号